Australia markets closed

Bioventus Inc. (BVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.4800-0.0700 (-1.54%)
At close: 04:00PM EDT
4.4800 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
516,697
512,345
512,117
430,898
321,161
Cost of revenue
172,038
184,152
181,037
128,192
87,642
Gross profit
344,659
328,193
331,080
302,706
233,519
Operating expenses
Research development
26,237
13,446
23,854
19,039
11,202
Selling general and administrative
335,819
303,879
332,134
254,253
193,078
Total operating expenses
378,156
326,167
365,736
281,655
211,719
Operating income or loss
-33,497
2,026
-34,656
21,051
21,800
Interest expense
11,882
40,676
12,021
1,112
9,751
Total other income/expenses net
-173,424
-82,461
-142,348
-10,451
3,865
Income before tax
-218,803
-121,111
-189,025
9,488
15,914
Income tax expense
-48,392
85
-44,374
-1,966
1,192
Income from continuing operations
-170,411
-121,196
-144,651
11,454
14,722
Net income
-127,138
-156,230
-158,704
19,375
16,411
Net income available to common shareholders
-127,138
-156,230
-158,704
19,375
16,411
Basic EPS
-2.92
-
-2.59
-0.15
0.44
Diluted EPS
-2.92
-
-2.59
-0.15
0.44
Basic average shares
62,353
-
61,389
59,549
37,697
Diluted average shares
62,353
-
61,389
59,549
37,697